Skip to main content
MedPathMedPath Home
Clinical Trials/ITMCTR1900002671
ITMCTR1900002671
Recruiting
Phase 1

Study for the mechanisms of recurrent urinary tract infections with postmenopausal women with Zhuolin Granules from the changes of urinary and intestinal microbiota

Changzhou Affiliated Hospital of Nanjing University of Chinese Medicine0 sitesTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRecurrent Urinary Tract Infection

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Recurrent Urinary Tract Infection
Sponsor
Changzhou Affiliated Hospital of Nanjing University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
Changzhou Affiliated Hospital of Nanjing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • •1\. meeting the diagnosis criteria of urinary tract infection;
  • •2\. symptomatic urinary tract infection (urinary frequency, urgency, dysuria; at least two symptoms);
  • •3\. had a documented history of three or more culture\-confirmed symptomatic episodes of uncomplicated UTI in the previous year;
  • •4\. menopausal (without menstruation for at least 12 months);
  • •6\. sign the informed consent.

Exclusion Criteria

  • •1\. Complicated urinary tract infections caused by urinary tract obstruction, indwelling catheter, diabetes mellitus and impaired immune function;
  • •2\. Urethral syndrome, asymptomatic bacteriuria;
  • •3\. Combined with serious heart, liver, kidney, hematopoietic system, endocrine, respiratory system and other diseases, malignant tumors or serious diseases affecting their survival;
  • •4\. Non\-bacterial infections (fungi, mycoplasma, chlamydia, parasites);
  • •5\. Allergic constitution, or known drug allergy patients used in this test;
  • •6\. Immune stimulation therapy was administered within one month before admission;
  • •7\. Patients participated in clinical trials of other drugs or antibiotics or probiotics were used in previous three months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Study of the mechanism of bladder recurrence after nephroureterectomypper urinary tract urothelial carcinoma
JPRN-UMIN000031014Tokyo Metropolitan Tama Medical Center50
Not yet recruiting
Not Applicable
Recurrent Urinary tract infection (rUTI)Health Condition 1: N390- Urinary tract infection, site notspecified
CTRI/2022/09/045671PG Dept of Moalejat General Medicine
Not yet recruiting
Not Applicable
Study of association between Urinary problems and metabolic syndrome(obesity,diabetes,hypertension,cholesterol problems)in men.
CTRI/2020/07/026948DRVIVEKANAND
Not yet recruiting
Not Applicable
To check relationship between diabetes mellitus and urinary tract infection , associated complication in hospital admitted patientsHealth Condition 1: E08-E13- Diabetes mellitusHealth Condition 2: N30-N39- Other diseases of the urinary system
CTRI/2023/06/053998Kasturba Hospital
Completed
Not Applicable
Investigation of factors which are related to urinary volume change after canagliflozin administratioType2 diabetes mellitus
JPRN-UMIN000019462Medical Corporation Hokubukai Utsukushigaoka Hospital, Clinical Pharmacology Center12